Clinical trial Recruiting at 5 sites Observational Ages 12 and up

Lung health in Canadians who use vaping devices

Official title: The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study

Run by University of British Columbia · NCT06819969 · Data updated 2026-11-12

This project will test new breathing tests, scans, and exercise measures to see if vaping harms the lungs of Canadian adolescents and adults.

Quick facts

Study typeObservational
Ages12 Years and up
SexAll
Enrollment500 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations8 sites (Edmonton, Alberta and 7 other locations)
StatusRecruiting
StartedJuly 25, 2025
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedMarch 30, 2026
Trial IDNCT06819969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Canadians who can attend a participating center and are either age 12–18 and never-smokers or exclusive e-cigarette users, or age 19+ and in one of four groups: never-users, exclusive cigarette smokers, exclusive e-cigarette users, or current dual users.

Probably not a fit

People with physician-diagnosed chronic lung disease, recent combustible cannabis use, recent cigarette smoking in adolescents, or those unable to complete pulmonary function and exercise testing may be excluded or are unlikely to gain direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CLOUD program is a pan-Canadian, multicentre, longitudinal effort that applies advanced imaging, novel pulmonary function tests, dynamic exercise testing, and airway cell sequencing to characterize vaping-related lung changes. It enrolls adolescents (12–18) and adults (19+) across user groups including never-users, exclusive e-cigarette users, exclusive cigarette smokers, and dual users. Participants undergo baseline and follow-up physiologic testing, imaging, exercise testing, and specimen collection to look specifically for small-airway injury. The study aims to define early signs of lung damage from vaping and improve detection across the lifespan.

Why it matters

Potential benefit: If successful, the project could identify early lung damage from vaping and give vapers and clinicians clearer information about risks and earlier detection.

How similar studies have gone: Prior case reports and smaller studies have linked vaping to lung injury, but comprehensive multicentre longitudinal phenotyping of small-airway disease using this combination of techniques is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adolescent arm:

* Aged ≥12 and \<19 years old
* Either 1) use neither combustible cigarettes nor e-cigarettes or 2) use e-cigarettes exclusively

Adult arm:

* Aged ≥19 years old
* Fall into one of the following categories: 1) use neither combustible cigarettes nor e-cigarettes; 2) use combustible cigarettes exclusively, never using e-cigarettes; 3) use e-cigarettes exclusively, never using combustible cigarettes; or 4) use both combustible cigarettes and e-cigarettes currently

Exclusion Criteria:

Adolescent arm:

* Contraindication to pulmonary function testing and cardiopulmonary exercise testing
* Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year
* Have smoked combustible cigarettes within the last 6 months
* Have a physician-diagnosed chronic lung disease (such as asthma, cystic fibrosis, or bronchopulmonary dysplasia)
* Inability to provide written informed consent

Adult arm:

* Contraindication to pulmonary function testing and cardiopulmonary exercise testing
* Have smoked combustible cannabis within the last month and/or have a combustible cannabis smoking history of \>1 joint-year
* Currently undergoing treatment for lung cancer
* Inability to provide written informed consent

No limitations will be placed on the type of e-liquids used by participants; e.g., e-cigarette users of nicotine, tetrahydrocannabinol, and cannabidiol will be all enrolled.

Where it's running

  • University of Alberta (Clinical Sciences Building)
    Edmonton, Alberta, Canada
    Recruiting
  • BC Cancer Agency
    Vancouver, British Columbia, Canada
    Recruiting
  • BC Children's Hospital Research Institute
    Vancouver, British Columbia, Canada
    Recruiting
  • St. Paul's Hospital
    Vancouver, British Columbia, Canada
    Recruiting
  • University of Ottawa (The Ottawa Hospital General Campus)
    Ottawa, Ontario, Canada
    Recruiting
  • McMaster University (Research Institute of St. Joe's Hamilton)
    Hamilton, Ontario, Canada
    Not yet recruiting
Show 2 more locations
  • University of Toronto (The Hospital for Sick Children)
    Toronto, Ontario, Canada
    Not yet recruiting
  • Université de Sherbrooke
    Sherbrooke, Quebec, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.